MYECO GROUP LTD — Director's Dealing 2015

Apr 22, 2015

==> picture [152 x 70] intentionally omitted <==

TO: COMPANY ANNOUNCEMENTS OFFICE ASX LIMITED DATE: 23 April 2015

CHANGE OF DIRECTOR’S INTEREST NOTICES

The Company wishes to announce change in the Director’s Interest of M/s Richard Tegoni and Gid Meltzer.

Appendices 3Y- Change of Director’s Interest Notice are attached.

Rekha Bhambhani Company Secretary

==> picture [593 x 63] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name	of entity – Cardia Bioplastics Limited
ABN-	89064755237

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr. Richard Tegoni
Date of last notice	6 January 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Change in Direct Interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	23 April 2015
No. of securities held prior to change	Direct Interest (On Post Consolidation basis) Mr. Richard Tegoni– 526,667 Ordinary Shares Tegoni Super Fund- 2,113,775 Ordinary Shares Indirect Interest (On Post Consolidation basis) Chocolate Investments Pty Ltd- 250,000 Ordinary Shares
Class	Fully Paid Ordinary Shares
Number acquired	75,000 Ordinary Shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Shares issued under Loan Share Plan in lieu of part remuneration payable to Richard Tegoni ($15,000) for the quarter ending 31 March 2015. The issue of these shares to Richard Tegoni was approved by shareholders at the Annual General Meeting held on 28 November 2014 (Resolution 7). The shares are issued at an issue price of $0.20/share (on post consolidation basis). The share issue price has been determined based on volume weighted average sale price of Cardia shares for 2015 March Quarter ($0.002/Share, pre-consolidation basis).
No. of securities held after change	Direct Interest (Post Consolidation basis) Mr. Richard Tegoni– 601,667 Ordinary Shares Tegoni Super Fund- 2,113,775 Ordinary Shares Indirect Interest (Post Consolidation basis) Chocolate Investments Pty Ltd- 250,000 Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Off- Market Trade Shares issued under Loan Share Plan in lieu of part remuneration payable for the quarter ending 31 March 2015.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name	of entity – Cardia Bioplastics Limited
ABN-	89 064755237

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr. Gideon Meltzer
Date of last notice	6 January 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Change in Direct Interest
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	23 April 2015

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	Direct Interest (Post Consolidation basis) Gideon Meltzer- 20,000 Ordinary Shares Indirect Interest (Post Consolidation basis) Jordmad Pty Ltd G&N\ Meltzer\ Superannuation Fund> 80,000 Ordinary Shares Jordmad Pty Ltd 33,334 Ordinary Shares
Class	Fully Paid Ordinary Shares
Number acquired	20,000 Ordinary Shares
Number disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Shares issued under Loan Share Plan in lieu of part remuneration payable to Gideon Meltzer ($4,000) for the quarter ending 31 March 2015. The issue of these shares to Gideon Meltzer was approved by shareholders at the Annual General Meeting held on 28 November 2014 (Resolution 8). The shares are issued at an issue price of $0.20/share (on post consolidation basis). The share issue price has been determined based on volume weighted average sale price of Cardia shares for 2015 March Quarter ($0.002/Share, pre-consolidation basis).
No. of securities held after change	Direct Interest Gideon Meltzer- 40,000 Ordinary Shares Indirect Interest Jordmad Pty Ltd G&N\ Meltzer\ Superannuation Fund> 80,000 Ordinary Shares Jordmad Pty Ltd 33,334Ordinary Shares
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Off- Market Trade Shares issued under Loan Share Plan in lieu of part remuneration payable for the quarter ending 31 March 2015.

Part 2 – Change of director’s interests in contracts

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3